INTRODUCTION
The initial categorization of inhibitory effect of malonyl-CoA on overt activity of carnitine palmitoyltransferase (CPT I) in mitochondria as competitive with respect to acyl-CoA substrate was made on the basis of the antagonization of inhibition by increasing concentrations of long-chain acyl-CoA. It has become evident, however, that the interaction of malonyl-CoA with CPT I must be more complex than could be accounted for solely by binding of the inhibitor at the active site of the enzyme. The observations that, when solubilized from the mitochondrial inner membrane, CPT I displays no inhibition by malonyl-CoA suggest that either malonylCoA never interacts with the active site of the enzyme (even when CPT I resides in the membrane) and/or that an allosteric-type effect of the inhibitor that permits such interaction is lost upon solubilization (Fiol & Bieber, 1984) . From studies on the pH-dependence of the affinity of CPT I for palmitoyl-CoA as a substrate and of the ability of palmitoyl-CoA to displace [14C]malonyl-CoA bound to skeletal-muscle mitochondria, Mills et al. (1984) have hypothesized that binding of palmitoyl-CoA at the active site is distinct from that which occurs at a second, malonyl-CoA-binding, site. In these mitochondria only one, high-affinity, class of binding sites for malonyl-CoA was observed (Mills et al., 1983) . In rat liver mitochondria there are at least two malonyl-CoA-binding sites, which have a greater than 10-fold difference in avidity for malonyl-CoA Bird & Saggerson, 1984) .
In spite of these indications of separate regulatory and catalytic sites on CPT I, there is no direct evidence for such an arrangement. No studies have been performed to ascertain the physical identity or otherwise of either, or both, of the malonyl-CoA-binding sites with the active site of CPT I in rat liver mitochondria (or mitochondria from other tissues). We were therefore interested in establishing directly whether blocking of the active site of CPT I affected the binding of [14C]malonyl-CoA to rat liver mitochondria and whether any residual malonylCoA binding could be displaced by palmitoyl-CoA, which, owing to the inaccessibility of the active site, would have to interact directly with the malonyl-CoAbinding site(s). The results suggest that malonyl-CoA binding to rat liver mitochondria is not decreased after blocking the active site by the self-catalysed formation of the S-carboxypalmitoyl-CoA ester of carnitine. In addition it is shown that palmitoyl-CoA only effectively displaces malonyl-CoA bound to the low-affinity site and not that bound to the high-affinity site on rat liver mitochondria. It is suggested that the regulatory site with low affinity for malonyl-CoA can be considered to be primarily a long-chain-acyl-CoA-binding site in vivo.
MATERIALS AND METHODS
The sources ofanimals and chemicals were as described previously (Zammit, 1980 (Zammit, , 1984 . In addition, 2-bromopalmitate was obtained from Aldrich Chemical Co. (Milwaukee, WI, U.S.A.), and CoA and ATP were from Sigma (Poole, Dorset, U.K.).
Mitochondria were isolated by differential centrifugation in a medium containing 300 mM-sucrose, 5 mMAbbreviation used: CPT, carnitine palmitoyltransferase (EC 2.3.1.21).
Tris/HCl and 1 mM-EGTA (pH 7.4 at 0°C) as described previously (Zammit, 1980) . They were suspended in 7.5 ml of medium containing 150 mM-KCl, 5 mmTris/HCl and 1 mM-EGTA (pH 7.4 at 0°C). Samples (3.5 ml) of this suspension were added to two tubes containing 22 ml ofKCl medium (pH 7.4 (Rial & Nicholls, 1983) . As described previously, initial rapid binding was followed by a slower increase in binding over the next 2-3 min . Thereafter there was no further increase in binding. Therefore, routinely, binding was performed for 5 min. CPT I activity was measured as described previously . Measurement of the rate of 02 uptake by mitochondria was performed polarographically also as described previously (Zammit, 1980) . Protein concentrations were measured as described by Lowry et al. (1951) .
RESULTS AND DISCUSSION
Effects of blocking of CPT I active site on 114Cimalonyl-CoA binding to rat liver mitochondria
In the present study CPT I activity was inhibited through the self-catalysed formation of the S-carboxypalmitoyl-CoA ester ofcarnitine, thus blocking the active site of the enzyme virtually irreversibly over the time scale of the experiments (Chase & Tubbs, 1969 , 1972 . This was achieved by incubating the mitochondria with 2-bromopalmitate, CoA, ATPMg and carnitine at 25 'C. Under these conditions the acyl-CoA synthetase activity of the outer membrane of the mitochondria catalyses the formation of2-bromopalmitoyl-CoA, which is a substrate for CPT I. On subsequent addition of carnitine, CPT I becomes inhibited through the formation of the S-carboxypalmitoyl-CoA ester of (-)-carnitine at the active site (Chase & Tubbs, 1972) . The enzyme has affinity for both the carnitine and the acyl-CoA moieties of this compound at the active site. This double affinity results in very tight binding of the compound; reversibility of the effect is extremely slow (Chase & Tubbs, 1969 , 1972 . Consequently the method provides a mechanism whereby an active-site-directed inhibitor can be used effectively to block further binding of acyl-CoA substrate or of any putative competitive ligand at the active site.
Inhibition of CPT I activity resulting from this treatment of the mitochondria was routinely over 90% [controls, 8.10+ 1.26 , treated, 0.80+0.29 (n = 6) nmol/min per mg of protein at 37°C]. The effect of 2-bromopalmitate had an absolute requirement for CoA and L-carnitine. In the presence of CoA, but in the absence of added carnitine, some inhibition (about 20% ) occurred. This is thought to have resulted from the effilux of carnitine from the mitochondrial matrix during incubation of the mitochondria at 25°C, owing to the uni-directional leak of carnitine mediated by the carnitine-acylcarnitine translocase of rat liver mitochondria (Pande & Parvin, 1980) . Therefore, routinely control mitochondria were treated with bromopalmitate and ATP only, whereas 'treated' mitochondria were incubated, in addition, with CoA and carnitine (see the Materials and methods section). Experiments in which bromopalmitate was replaced by an equivalent concentration of palmitate (in the presence of CoA, ATP and carnitine) resulted in no inhibition of CPT I activity, thus establishing the requirement for bromopalmitate in order to observe inhibition of CPT I. This method minimized the amount of acyl-CoA to which the mitochondria were exposed during the preincubation period at 25°C and ensured that the mitochondria could subsequently be washed free of the low concentration (20 fM) of bromopalmitate. Because bromopalmitoyl-CoA may itself be an inhibitor of acyl-CoA synthetase (Mahadevan & Sauer, 1971) , only minimal amounts of bromopalmitoyl-CoA are likely to be synthesized by the mitochondria, but these are sufficient to induce inhibition of CPT I on further addition ofcarnitine (Chase & Tubbs, 1972) . That the mitochondria were functionally intact after this treatment was confirmed by measurement of their rate of 02 consumption under different conditions. Treated mitochondria showed normal, high, respiratory control ratios (7-10) with glutamate and malate as substrates. Oxidation of palmitoyl-CoA in the presence of carnitine was almost totally abolished (> 95% ; cf. CPT I activity above), whereas oxidation of palmitoyl-L-carnitine was unaffected. The State-3 rate of respiration with glutamate and malate as substrates was also unaffected (results not shown).
Inhibition of CPT I did not result in inhibition of the binding of [14C]malonyl-CoA to rat liver mitochondria (Fig. 1) . The complex bimodal concentration-dependence of malonyl-CoA binding (cf. Zammit et al., 1984; Bird & Saggerson, 1984) was also unaffected by CPT I inhibition (see also Fig. 3 on mitochondria (Mills et al., 1984; Bird & Saggerson, 1984) , it should be able to do so through direct competition with this allosteric site(s), since it became obvious that occupation of the active site was not by itself sufficient to affect displacement. In order to test this inference directly, we performed experiments in which binding of [14C]malonyl-CoA to mitochondria that had been treated with bromopalmitate (plus CoA, ATPMg and carnitine) was measured in the presence and absence of palmitoylCoA. Preliminary experiments had established that 100 /tM-palmitoyl-CoA gave near-maximal displacement (Fig. 2) . Much higher concentrations (> 400 ,UM) of palmitoyl-CoA resulted in total loss of specific association of malonyl-CoA with the mitochondria; this was probably due to detergent effects, since it also resulted in a large increase in the activity of CPT that could be measured (results not shown). The results showed that palmitoyl-CoA was only partially able to displace malonyl-CoA (Fig. 2) . It displaced the inhibitor from its low-affinity site, but was largely, if not totally, ineffective in displacing malonyl-CoA from its high-affinity site (Fig.  3) . Consequently the bimodal, two-site, binding pattern obtained in the absence ofpalmitoyl-CoA (see above) was transformed by palmitoyl-CoA into a unimodal pattern characteristic of high-affinity binding which approached saturation hyperbolically (Fig. 3a) . This differential effect of palmitoyl-CoA on the two components is more strikingly obvious from Scatchard-type plots of the data ( Fig. 3b ; but see below). Only low-affinity binding was lost in the presence of palmitoyl-CoA, as indicated from the Scatchard plot for the degree of binding lost at different malonyl-CoA concentrations (Fig. 3b) . When the characteristics of the [14C]malonyl-CoAbinding capacity lost in the presence of palmitoyl-CoA were examined quantitatively by subtraction of the respective mean values abstracted from the two curves in Fig. 3(a) , evidence emerged that the low-affinity, high-capacity, component of [14C]malonyl-CoA binding approached saturation in a sigmoidal manner. This was also evident from the Scatchard plot for this component (Fig. 3b) . Therefore the two components ofmalonyl-CoA binding to rat liver mitochondria Bird & Saggerson, 1984) appear to differ not only in relative affinity and capacity but also in their saturation kinetics. It is possible that the sigmoidal nature of the low-affinity component could result from genuine allosteric-type co-operative interaction between the protomers of CPT I, which is known to be a tetrameric protein (Miyazawa et al., 1983) . We have obtained further evidence for these characteristics of the two components, using a different experimental approach (Zammit & Corstorphine, 1985b respective kinetic parameters would present problems. This is because implicit in such a mathematical treatment is the assumption that saturation kinetics of the multiple binding components all obey Michaelis-Menten-type equations. Consequently we would like to restrict the use of Scatchard plots to illustrative purposes (Fig. 3b) rather than use them for quantitative derivation of binding parameters. In this respect, the present observation of sigmoidal saturation kinetics for the low-affinity component may partly explain the paradoxical apparent 5-fold increase in the number of high-affinity binding sites in the presence of palmitoyl-CoA (Bird & Saggerson, 1984 These characteristics of the high-and low-affinity components may also explain why the degree of inhibition of CPT I by different malonyl-CoA concentrations and the site-occupancy of the high-affinity site calculated from the two-hyperbola model are only modestly correlated for rat liver mitochondria (Bird & Saggerson, 1984) .
Physiological considerations
The present findings establish that malonyl-CoA does not bind to the active site of CPT I. Moreover they raise the possibility that there are two regulatory sites associated with the enzyme: one that binds malonyl-CoA with high affinity and appears not to be susceptible to appreciable competition by acyl-CoA, and a second site that must be considered as essentially an acyl-CoA-binding site under conditions in vivo. Thus the half-maximally effective concentration of malonyl-CoA in saturating this low-affinity site is apparently > 25 ItM (cf. Zammit et al., 1984; Bird & Saggerson, 1984) , i.e. well above the physiological range of malonyl-CoA concentrations (see, e.g., Zammit, 1981) . Conversely, palmitoyl-CoA displaces malonyl-CoA from this site very effectively even at low concentrations (Fig. 2) . The concentrations of palmitoylCoA required to achieve virtually total displacement are likely to occur in vivo, as indicated by the fact that 100 /uM-palmitoyl-CoA (in the presence of 10 mg of albumin/ml) gives about 70% of maximal CPT I activity in vitro (results not shown), whereas it is known that, under conditions characterized by increased delivery of fatty acids to the liver in vivo, the CPT I reaction appears to attain saturation with acyl-CoA substrate (see Zammit, 1984, for review) .
It is noteworthy that half-maximal residual binding of malonyl-CoA in the presence of 100 ,uM-palmitoyl-CoA occurred at 2-4 gM-malonyl-CoA (Fig. 3a) . This observation is significant in terms both of the similarity of this value to the corresponding concentration required to achieve half-maximal inhibiton of CPT I in vitro under similar conditions (Zammit & Corstorphine, 1985a) and of the fact that it is within the range of malonyl-CoA concentrations that occur in the liver in vivo (Zammit, 1981) . The question arises as to whether the allosteric binding sites for malonyl-CoA and acyl-CoA occur on the same protein species ('allosteric' is used to denote non-active-site binding). It has been hypothesized that malonyl-CoA may exert its effects on CPT I activity by binding to a separate regulatory protein associated with CPT I in the mitochondrial inner membrane (Bieber & Farrell, 1983; Foster, 1984) . Several aspects of the present findings can be interpreted as providing support for such a hypothesis. Thus, whereas the concentrationdependence of the malonyl-CoA binding to the highaffinity site was hyperbolic, there was evidence that the site with low affinity for malonyl-CoA approached saturation sigmoidally (Fig. 3a) . It of which is capable of exhibiting co-operative-type interactions between its component promoters. In this respect it is noteworthy that CPT activity exhibits co-operative-type kinetics with respect of acyl-CoA substrate both when the enzyme resides in the mitochondrial inner membrane (CPT I; Saggerson & Carpenter, 1981; Cook, 1984) and after purification (at least for the bovine heart enzyme; Fiol & Bieber, 1984) . Therefore the sigmoidal characteristics of acyl-CoA saturation at the active site and of the low-affinity malonyl-CoA (highaffinity acyl-CoA) binding to rat liver mitochondria may derive from the fact that they both reside on the same oligomeric protein (CPT has been shown to be a tetramer; Miyazawa et al., 1983) . However, although the data presented in this paper lend support to the concept of a separate monomeric malonyl-CoA-binding protein that interacts with an oligomeric CPT I within the mitochondria inner-membrane environment, it must be emphasized that such evidence is entirely circumstantial. Nevertheless, the demonstration that blocking the active site of CPT I does not interfere with malonyl-CoA (and acyl-CoA) binding at allosteric sites is physiologically significant. It provides the basis for a mechanism whereby changes in both malonyl-CoA and palmitoyl-CoA concentrations in vivo can exert their respective effects on the catalytic activity of CPT I without the requirement for direct competition between the two ligands for the active site.
